Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD80 (Galiximab Biosimilar) Antikörper

Reaktivität: Human IP, WB, BR, ELISA, FACS, IHC Wirt: Human Monoclonal IDEC-114 unconjugated Recombinant Antibody
Produktnummer ABIN7072387
  • Target Alle CD80 (Galiximab Biosimilar) Produkte
    CD80 (Galiximab Biosimilar)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    Human
    Wirt
    • 1
    • 1
    Human
    Klonalität
    • 1
    • 1
    Monoklonal
    Konjugat
    • 2
    Dieser CD80 (Galiximab Biosimilar) Antikörper ist unkonjugiert
    Applikation
    Immunoprecipitation (IP), Western Blotting (WB), Blocking Reagent (BR), ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC)
    Verwendungszweck
    Anti-CD80 [IDEC-114 (Galiximab)], Human IgG1, lambda
    Spezifität
    Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80. CD80 is a surface glycoprotein and a member of the B7 family of costimulatory molecules. CD80 antigen regulates T cell activation (through interacting with CD28 or CD152) and is expressed transiently in antigen-presenting cells, T cells and normal B cells, and expressed consitutively on various subtypes of B-cell lymphomas.
    Produktmerkmale

    Original Species of Ab: Human

    Original Format of Ab: IgG1

    Aufreinigung
    Protein A affinity purified
    Immunogen
    Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013)
    Klon
    IDEC-114
    Isotyp
    IgG1 lambda
  • Applikationshinweise
    Galiximab acts to decrease in cell proliferation, inhibition of the constitutively active NF-κB pathway, increase in apoptosis and ADCC against various B-cell lymphoma cell lines. Galiximb affects CD28 and CD152 interactions with CD80. This antibody can also be used for FC, WB, ELISA, IP and IHC.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    CD80 (Galiximab Biosimilar)
    Abstract
    CD80 (Galiximab Biosimilar) Produkte
    Substanzklasse
    Biosimilar
    Hintergrund
    B7-1, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7
    UniProt
    P33681
Sie sind hier:
Kundenservice